Research Article
Assessment of the Concentration of Bone Metabolism Markers: Sclerostin and FGF-23 in Children with Idiopathic Nephrotic Syndrome Treated with Glucocorticosteroids
Table 1
The patient characteristics.
| 
 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Data are presented as median values and interquartile ranges. | |||||||||||||||||||||||||||||||||||||||||||||||||||